You are here

Bioiberica at EULAR, ACR and OARSI Conferences

2 Feb 2009
Healthcare

Bioiberica closed 2008 by participating in the three most important international conferences on diseases of the musculoskeletal system: those organized by EULAR, OARSI and ACR.

Bioiberica presented new clinical-efficacy and safety data on chondroitin, as well as a new line of scientific research on the product as a modulator of chronic inflammation.

Related News

29 May 2022
Healthcare

With World Digestive Health Day around, shortly followed by World Allergy Awareness Week (5-11 June), we’re exploring the increasing relevance of a relatively unknown digestive health disorder – histamine intolerance.

25 May 2022
Healthcare

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.

17 Apr 2022
Healthcare

Bioiberica unveils DAOgest and Dermial® for the first time at Vitafoods 2022.